Quetiapine Tablet, Extended Release
Product Images NDC 68001-600

14 FDA label images from Bluepoint Laboratories · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Quetiapine (NDC 68001-600). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bluepoint Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (3ec5c4ad 8a55 4091 Ada4 4e009332a5ec 01)

Image (3ec5c4ad 8a55 4091 Ada4 4e009332a5ec 01)
Chemical structure of Quetiapine fumarate, showing the molecular arrangement of quetiapine with the fumarate moiety, as used in the pharmaceutical formulation.*
FDA Label Image

Image (3ec5c4ad 8a55 4091 Ada4 4e009332a5ec 02)

Image (3ec5c4ad 8a55 4091 Ada4 4e009332a5ec 02)
A Kaplan-Meier curve showing the proportion of patients with relapse (%) over time in months for two groups: PLA (placebo) and QTP XR (Quetiapine extended release). The graph compares relapse rates over a 7-month period, with PLA showing a higher relapse proportion than QTP XR.*
FDA Label Image

Image (3ec5c4ad 8a55 4091 Ada4 4e009332a5ec 03)

Image (3ec5c4ad 8a55 4091 Ada4 4e009332a5ec 03)
A line graph depicting the proportion of patients with relapse (%) over time (weeks). Two groups are compared: QTP+LIVAL and PLA+LIVAL, showing differing relapse rates across a 100-week period.*
FDA Label Image

Image (3ec5c4ad 8a55 4091 Ada4 4e009332a5ec 04)

Image (3ec5c4ad 8a55 4091 Ada4 4e009332a5ec 04)
A line graph depicting the proportion of patients with relapse (%) over time in weeks, comparing two groups labeled QTP+ LI/VAL and PLA+ LI/VAL. The graph shows the relapse proportion increasing over approximately 100 weeks for both groups, with PLA+ LI/VAL consistently higher than QTP+ LI/VAL.*
FDA Label Image

Quetiapine 400mg Rev 07/2025 (Quetiapine Er Tablet Usp 400mg Labels Rev 072025)

Quetiapine 400mg Rev 07/2025 (Quetiapine Er Tablet Usp 400mg Labels Rev 072025)
Label for Quetiapine Extended-Release Tablets, USP 400 mg manufactured by Unichem Laboratories Ltd. and labeled by BluePoint Laboratories. The label states each tablet contains 460.52 mg of quetiapine fumarate equivalent to 400 mg quetiapine, for oral use once daily. The package contains 60 tablets and includes storage instructions and warnings.*
FDA Label Image

Quetiapine Er Tabs 300mg Rev 07/2025 (Quetiapine Er Tablet Usp 300mg Labels Rev 072025)

Quetiapine Er Tabs 300mg Rev 07/2025 (Quetiapine Er Tablet Usp 300mg Labels Rev 072025)
Label for Quetiapine Extended-Release Tablets, USP 300 mg by BluePoint Laboratories. The oral extended-release tablets come in a package of 60 tablets. The label includes storage instructions, usage warnings, and pharmacist dispensing information. Manufactured by Unichem Laboratories Ltd., India.*
FDA Label Image

Quetiapine Er Tab 200mg Rev 07/2025 (Quetiapine Er Tablet Usp 200mg Labels Rev 072025)

Quetiapine Er Tab 200mg Rev 07/2025 (Quetiapine Er Tablet Usp 200mg Labels Rev 072025)
Packaging label for Quetiapine Extended-Release Tablets, USP 200 mg, oral tablets in a count of 60. The label includes manufacturer information, BluePoint Laboratories as labeler, storage instructions, usage directions, and a barcode. The product is labeled as prescription only (Rx Only) and manufactured by Unichem Laboratories Ltd, India.*
FDA Label Image

Quetiapine Er 150mg Rev 07/2025 (Quetiapine Er Tablet Usp 150mg Labels Rev 072025)

Quetiapine Er 150mg Rev 07/2025 (Quetiapine Er Tablet Usp 150mg Labels Rev 072025)
Label for Quetiapine Extended-Release Tablets, USP 150 mg by BluePoint Laboratories. The label includes dosage form as extended-release tablets, oral route, package count of 60 tablets. Manufacturer is Unichem Laboratories Ltd., India. The label provides dosage instructions, storage conditions, and a barcode.*
FDA Label Image

Quetiapine Er Tab 50mg Rev 07/2025 (Quetiapine Er Tablet Usp 50mg Labels Rev 072025)

Quetiapine Er Tab 50mg Rev 07/2025 (Quetiapine Er Tablet Usp 50mg Labels Rev 072025)
Packaging label for Quetiapine Extended-Release Tablets, USP 50 mg from BluePoint Laboratories. The label includes dosage details, storage instructions, a barcode, and manufacturer information indicating Unichem Laboratories Ltd in India. The package contains 60 extended-release oral tablets.*
FDA Label Image

Quetiapine Er Tab 50mg (3ec5c4ad 8a55 4091 Ada4 4e009332a5ec 06)

Quetiapine Er Tab 50mg (3ec5c4ad 8a55 4091 Ada4 4e009332a5ec 06)
Label for Quetiapine Extended-Release Tablets, USP 50 mg by BluePoint Laboratories. The label states the dosage form as extended-release tablets with 50 mg strength, containing 57.57 mg of Quetiapine Fumarate USP equivalent to 50 mg of Quetiapine. It includes storage instructions (20°C to 25°C), usual dosage (once daily), and manufacturer information: Unichem Laboratories Ltd., India. The package contains 60 tablets.*
FDA Label Image

Quetiapine Er Tabs 150mg (3ec5c4ad 8a55 4091 Ada4 4e009332a5ec 07)

Quetiapine Er Tabs 150mg (3ec5c4ad 8a55 4091 Ada4 4e009332a5ec 07)
Label for Quetiapine Extended-Release Tablets, USP 150 mg by BluePoint Laboratories. It is an oral tablet with 60 tablets per container. Manufactured by Unichem Laboratories Ltd., India. The label includes storage instructions, dosage guidance as once daily, and a warning to keep out of reach of children. NDC 68001-599-06.*
FDA Label Image

Quetiapine Er Tabs 200mg (3ec5c4ad 8a55 4091 Ada4 4e009332a5ec 08)

Quetiapine Er Tabs 200mg (3ec5c4ad 8a55 4091 Ada4 4e009332a5ec 08)
This label panel for Quetiapine Extended-Release Tablets, USP shows the 200 mg strength, with directions to swallow whole and not to split or chew. It includes storage instructions, a warning to keep out of children's reach, and advises pharmacists to provide the medication guide. The label indicates the manufacturer as UNICHEM LABORATORIES LTD. and the labeler as BluePoint Laboratories. The package contains 60 tablets.*
FDA Label Image

Quetiapine Er Tabs 300mg (3ec5c4ad 8a55 4091 Ada4 4e009332a5ec 09)

Quetiapine Er Tabs 300mg (3ec5c4ad 8a55 4091 Ada4 4e009332a5ec 09)
Label for Quetiapine Extended-Release Tablets, USP 300 mg, oral tablet, extended release form. The label includes dosage instructions, storage conditions, and warnings. It is manufactured by Unichem Laboratories Ltd. for BluePoint Laboratories. The package contains 60 tablets and is marked Rx Only with NDC 68001-601-06.*
FDA Label Image

Quetiapine Er Tabs 400mg (3ec5c4ad 8a55 4091 Ada4 4e009332a5ec 10)

Quetiapine Er Tabs 400mg (3ec5c4ad 8a55 4091 Ada4 4e009332a5ec 10)
Label for Quetiapine Extended-Release Tablets, USP 400 mg oral tablets by BluePoint Laboratories. The label states each extended-release tablet contains 460.52 mg Quetiapine Fumarate USP, equivalent to 400 mg Quetiapine, with instructions to swallow whole without splitting or crushing. The package contains 60 tablets and is manufactured by Unichem Laboratories Ltd in India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.